Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy

被引:0
|
作者
Dan Călugăru
Mihai Călugăru
机构
[1] University of Medicine Cluj-Napoca/Romania,Department of Ophthalmology
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2018年 / 256卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:233 / 235
页数:2
相关论文
共 50 条
  • [31] Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
    Wataru, Kikushima
    Sugiyama, Atsushi
    Yoneyama, Seigo
    Matsubara, Mio
    Fukuda, Yoshiko
    Parikh, Ravi
    Sakurada, Yoichi
    PLOS ONE, 2020, 15 (02):
  • [32] Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
    Weng, Hsin-Yu
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Ho, Wei-Ting
    Hsu, Yung-Ray
    Chen, Fang-Ting
    Chen, Yun-Ju
    Wang, Jia-Kang
    APPLIED SCIENCES-BASEL, 2021, 11 (03): : 1 - 9
  • [33] Choroidal Thickness in Polypoidal Choroidal Vasculopathy After Switching to Intravitreal Aflibercept Injection
    Ise, Shigeyuki
    Saito, Masaaki
    Sugano, Yukinori
    Ojima, Akira
    Sekiryu, Tetsuju
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [34] Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
    Sang Eun Lee
    Jun Won Jang
    Se Woong Kang
    Kyu Hyung Park
    Dong Won Lee
    Jae Hui Kim
    KunHo Bae
    Scientific Reports, 9
  • [35] ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Hara, Chikako
    Sawa, Miki
    Sayanagi, Kaori
    Nishida, Kohji
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (01): : 37 - 45
  • [36] Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
    Lee, Sang Eun
    Jang, Jun Won
    Kang, Se Woong
    Park, Kyu Hyung
    Lee, Dong Won
    Kim, Jae Hui
    Bae, KunHo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [37] One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
    Yamamoto, Akiko
    Okada, Annabelle A.
    Kano, Mariko
    Koizumi, Hideki
    Saito, Masaaki
    Maruko, Ichiro
    Sekiryu, Tetsuju
    Iida, Tomohiro
    OPHTHALMOLOGY, 2015, 122 (09) : 1866 - 1872
  • [38] Treatment Responses to the Intravitreal Aflibercept in Polypoidal Choroidal Vasculopathy at 1 year
    Minami, Sakiko
    Nagai, Norihiro
    Suzuki, Misa
    Kurihara, Toshihide
    Shinoda, Hajime
    Tsubota, Kazuo
    Ozawa, Yoko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [39] Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
    Miura, Masahiro
    Iwasaki, Takuya
    Goto, Hiroshi
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1591 - 1595
  • [40] SWITCHING TO INTRAVITREAL AFLIBERCEPT INJECTION FOR POLYPOIDAL CHOROIDAL VASCULOPATHY REFRACTORY TO RANIBIZUMAB
    Saito, Masaaki
    Kano, Mariko
    Itagaki, Kanako
    Oguchi, Yasuharu
    Sekiryu, Tetsuju
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (11): : 2192 - 2201